The global antibodies contract manufacturing market size was estimated at USD 17.79 billion in 2024 and is projected to reach USD 31.76 billion by 2030, growing at a CAGR of 10.1% from 2025 to 2030. This strong growth is primarily driven by the increasing focus of biopharmaceutical and biotechnology companies on the development and large-scale manufacturing of antibody-based therapeutics....